Czaplinska et al. have found that FGFR2 levels are higher in normal breast tissue compared to breast carcinomas, and our results suggest that FGFR2 levels are higher in luminal subtypes than the more aggressive TNBC, and the lowest in HER2-positive cancers [66]. Here, ERBB2 is linked to cancer.